Micrograph News and Research

RSS
SARS-CoV-2 a "swarm" of mutant viruses

SARS-CoV-2 a "swarm" of mutant viruses

Can SARS-CoV-2 be transmitted via feces?

Can SARS-CoV-2 be transmitted via feces?

Inhaled delivery of a potent neutralizing nanobody effective against SARS-CoV-2

Inhaled delivery of a potent neutralizing nanobody effective against SARS-CoV-2

Vaccine 'nationalism' will slow coronavirus fight if poor countries are left exposed

Vaccine 'nationalism' will slow coronavirus fight if poor countries are left exposed

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen

Heat suggested as a therapeutic intervention in COVID-19

Heat suggested as a therapeutic intervention in COVID-19

Mice study shows a promising therapy for spinal cord injuries

Mice study shows a promising therapy for spinal cord injuries

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

SARS-CoV-2 spike protein recognized by innate immune receptors in a glycan-dependent way

SARS-CoV-2 spike protein recognized by innate immune receptors in a glycan-dependent way

Severe fatigue common in COVID-19, independent of disease severity

Severe fatigue common in COVID-19, independent of disease severity

New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2

New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2

Children carry 100 times more SARS-CoV-2 virus as adults, study says

Children carry 100 times more SARS-CoV-2 virus as adults, study says

Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses

Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses

People with SARS-CoV-2 most infectious in days 0-5, no evidence of transmission after day 9

People with SARS-CoV-2 most infectious in days 0-5, no evidence of transmission after day 9

Experimental vaccine rapidly controls coronavirus in the upper and lower airways of nonhuman primates

Experimental vaccine rapidly controls coronavirus in the upper and lower airways of nonhuman primates

Moderna coronavirus vaccine candidate moves to phase 3 with 30,000 participants

Moderna coronavirus vaccine candidate moves to phase 3 with 30,000 participants

National clinical trial to test potential vaccine against SARS-CoV-2

National clinical trial to test potential vaccine against SARS-CoV-2

Pfizer/BioNTech COVID-19 vaccine elicits both neutralizing antibodies and T cell response

Pfizer/BioNTech COVID-19 vaccine elicits both neutralizing antibodies and T cell response